89 related articles for article (PubMed ID: 9850732)
1. Transforming growth factor-beta protection of cancer cells against tumor necrosis factor cytotoxicity is counteracted by hyaluronidase (review).
Chang NS
Int J Mol Med; 1998 Dec; 2(6):653-9. PubMed ID: 9850732
[TBL] [Abstract][Full Text] [Related]
2. Cloning and characterization of a transforming growth factor beta 1-induced anti-apoptotic adhesion protein TIF2.
Carey GB; Chang NS
Biochem Biophys Res Commun; 1998 Aug; 249(1):283-6. PubMed ID: 9705873
[TBL] [Abstract][Full Text] [Related]
3. Interleukin 1, interleukin 6, tumor necrosis factor, and transforming growth factor beta increase cell resistance to tumor necrosis factor cytotoxicity by growth arrest in the G1 phase of the cell cycle.
Belizario JE; Dinarello CA
Cancer Res; 1991 May; 51(9):2379-85. PubMed ID: 2015601
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronidase activation of c-Jun N-terminal kinase is necessary for protection of L929 fibrosarcoma cells from staurosporine-mediated cell death.
Chang NS
Biochem Biophys Res Commun; 2001 May; 283(2):278-86. PubMed ID: 11327694
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha-induced antiproliferation is not dependent on the autocrine action of TGF-beta 1 in a thyroid cancer cell line.
Pang XP; Yoshimura M; Wang J; Dubinett SM
Lymphokine Cytokine Res; 1994 Apr; 13(2):93-7. PubMed ID: 8061120
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-beta suppresses tumor necrosis factor alpha-induced matrix metalloproteinase-9 expression in monocytes.
Vaday GG; Schor H; Rahat MA; Lahat N; Lider O
J Leukoc Biol; 2001 Apr; 69(4):613-21. PubMed ID: 11310848
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of transforming growth factor beta signaling in MCF-7 cells results in resistance to tumor necrosis factor alpha: a role for Bcl-2.
Tobin SW; Brown MK; Douville K; Payne DC; Eastman A; Arrick BA
Cell Growth Differ; 2001 Feb; 12(2):109-17. PubMed ID: 11243465
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor-beta1 blocks the enhancement of tumor necrosis factor cytotoxicity by hyaluronidase Hyal-2 in L929 fibroblasts.
Chang NS
BMC Cell Biol; 2002 Apr; 3():8. PubMed ID: 11960552
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor alpha enhances secretion of transforming growth factor beta2 in MCF-7 breast cancer cells.
Danforth DN; Sgagias MK
Clin Cancer Res; 1996 May; 2(5):827-35. PubMed ID: 9816237
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta-induced matrix proteins inhibit p42/44 MAPK and JNK activation and suppress TNF-mediated IkappaBalpha degradation and NF-kappaB nuclear translocation in L929 fibroblasts.
Chang NS
Biochem Biophys Res Commun; 2000 Jan; 267(1):194-200. PubMed ID: 10623598
[TBL] [Abstract][Full Text] [Related]
12. TNF-alpha, PDGF, and TGF-beta(1) expression by primary mouse bronchiolar-alveolar epithelial and mesenchymal cells: tnf-alpha induces TGF-beta(1).
Warshamana GS; Corti M; Brody AR
Exp Mol Pathol; 2001 Aug; 71(1):13-33. PubMed ID: 11502094
[TBL] [Abstract][Full Text] [Related]
13. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
Boldrini L; Calcinai A; Samaritani E; Pistolesi F; Mussi A; Lucchi M; Angeletti CA; Basolo F; Fontanini G
Br J Cancer; 2000 Aug; 83(4):480-6. PubMed ID: 10945495
[TBL] [Abstract][Full Text] [Related]
14. Cooperation between SMAD and NF-kappaB in growth factor regulated type VII collagen gene expression.
Kon A; Vindevoghel L; Kouba DJ; Fujimura Y; Uitto J; Mauviel A
Oncogene; 1999 Mar; 18(10):1837-44. PubMed ID: 10086338
[TBL] [Abstract][Full Text] [Related]
15. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
Braundmeier AG; Nowak RA
Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
[TBL] [Abstract][Full Text] [Related]
16. Differential mechanisms of plasminogen activator inhibitor-1 gene activation by transforming growth factor-beta and tumor necrosis factor-alpha in endothelial cells.
Chen YQ; Sloan-Lancaster J; Berg DT; Richardson MA; Grinnell B; Tseng-Crank J
Thromb Haemost; 2001 Dec; 86(6):1563-72. PubMed ID: 11776328
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor (TNF) receptor-2-mediated DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: The involvement of endogenous transforming growth factor-alpha.
Okamoto H; Kimura M; Watanabe N; Ogihara M
Eur J Pharmacol; 2009 Feb; 604(1-3):12-9. PubMed ID: 19100731
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional and translational regulation of inflammatory mediator production by endogenous TGF-beta in macrophages that have ingested apoptotic cells.
McDonald PP; Fadok VA; Bratton D; Henson PM
J Immunol; 1999 Dec; 163(11):6164-72. PubMed ID: 10570307
[TBL] [Abstract][Full Text] [Related]
19. The role for transforming growth factor-beta (TGF-beta) in human cancer.
Gold LI
Crit Rev Oncog; 1999; 10(4):303-60. PubMed ID: 10654929
[TBL] [Abstract][Full Text] [Related]
20. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
